Katherine B. Peters

Recurrent Glioblastoma Treated with Recombinant Poliovirus

Annick Desjardins, Matthias Gromeier, James E. Herndon et al. · New England Journal of Medicine · 2018 · 768 citations · Full text

Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma

Ingo K. Mellinghoff, Martin J. van den Bent, Deborah T. Blumenthal et al. · New England Journal of Medicine · 2023 · 606 citations · Full text

Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology

Burt Nabors, Jana Portnow, Manmeet S. Ahluwalia et al. · Journal of the National Comprehensive Cancer Network · 2020 · 538 citations · Full text

Surgical Oncology, Cancer Management, High-grade Gliomas +19

Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth.

Peiliang Lin, Peter J. Polverini, Mark W. Dewhirst et al. · Journal of Clinical Investigation · 1997 · 254 citations · Full text

Pathologic Vascular Growth, Tie2 Ligand, Pathology +18

Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma

Lakshmi Nayak, Annette M. Molinaro, Katherine B. Peters et al. · Clinical Cancer Research · 2020 · 238 citations · Full text